INSM

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,134

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.56 to $28.82, inclusive.

SEC source: 0001127430-17-000079 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,262

F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.84 to $29.20, inclusive.

F7 · balance_after: The number of shares reflected here excludes 443 shares previously reported for which Dr. Sharoky does not have beneficial ownership.

SEC source: 0001127430-17-000078 · edgar.xml · derivative · entry 8

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 15,000 shares

Expires 2021-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000078 · edgar.xml · derivative · entry 7

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 15,000 shares

Expires 2021-12-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000078 · edgar.xml · nonDerivative · entry 4

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,131

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001127430-17-000078 · edgar.xml · nonDerivative · entry 3

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001127430-17-000078 · edgar.xml · nonDerivative · entry 2

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,131

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001127430-17-000078 · edgar.xml · nonDerivative · entry 1

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

SEC source: 0001127430-17-000071 · edgar.xml · derivative · entry 1

STRECK PAUL · CIK 0001708063 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,210

Underlying: Common Stock · 109,210 shares

Expires 2027-06-05

F1 · derivative.exercise_date: In connection with the appointment of Dr. Streck as the Company's Chief Medical Officer, the Company granted Dr. Streck an option to purchase a total of 109,210 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Dr. Streck's continued employment with the Company on each vesting date.

SEC source: 0001127430-17-000065 · edgar.xml · derivative · entry 1

TOMBESI PAOLO · CIK 0001707648 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,160

Underlying: Common Stock · 127,160 shares

Expires 2027-06-01

F1 · derivative.exercise_date: In connection with the appointment of Mr. Tombesi as the Company's Chief Financial Officer, the Company granted Mr. Tombesi an option to purchase a total of 127,160 shares of the Company's common stock. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date through the fourth anniversary of the date of grant, subject to Mr. Tombesi's continued employment with the Company on each vesting date.

SEC source: 0001127430-17-000059 · edgar.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

F2 · price: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.83 to $14.96, inclusive.

SEC source: 0001127430-17-000059 · edgar.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,300

F1 · price: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.14 to $15.30, inclusive. The reporting person undertakes to provide to Insmed Incorporated, any security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and footnote (2).

SEC source: 0001127430-17-000051 · edgar.xml · derivative · entry 1

SULLIVAN EUGENE JEFFREY · CIK 0001637226 · Chief Med. & Scientific Ofc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,300

Underlying: Common Stock · 33,300 shares

Expires 2027-05-17

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000050 · edgar.xml · derivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,300

Underlying: Common Stock · 38,300 shares

Expires 2027-05-17

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000049 · edgar.xml · derivative · entry 1

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,780

Underlying: Common Stock · 60,780 shares

Expires 2027-05-17

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000048 · edgar.xml · derivative · entry 1

Lewis William · CIK 0001402051 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,080

Underlying: Common Stock · 142,080 shares

Expires 2027-05-17

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000047 · edgar.xml · derivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,600

Underlying: Common Stock · 76,600 shares

Expires 2027-05-17

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000046 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,171

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000045 · edgar.xml · nonDerivative · entry 1

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,444

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000044 · edgar.xml · nonDerivative · entry 1

MCGIRR DAVID W J · CIK 0001219023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,296

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000043 · edgar.xml · nonDerivative · entry 1

HAYDEN DONALD J JR · CIK 0001202285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,131

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000042 · edgar.xml · nonDerivative · entry 1

ENGELSEN STEINAR J · CIK 0001218860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,152

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000041 · edgar.xml · nonDerivative · entry 1

Brennan David R · CIK 0001609305 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,256

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000040 · edgar.xml · nonDerivative · entry 1

ALTOMARI ALFRED · CIK 0001285644 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,876

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was received as a grant on May 17, 2017, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-18-000043 · edgar.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 231,794

F1 · shares: The Restricted Stock Units have a one year cliff vesting period, provided that the director (a) remains a member of the Board on such vesting date, and (b) attends at least 75% of the meetings of the Board which take place between the grant date and the first anniversary of the grant date. Vested shares are delivered within 30 days of vesting date.

F2 · price: Each Restricted Stock Unit was granted on May 15, 2018, and represents a contingent right to receive one share of Common Stock.

SEC source: 0001127430-17-000017 · edgar.xml · derivative · entry 5

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,145

Underlying: Common Stock · 10,000 shares

Expires 2022-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000017 · edgar.xml · derivative · entry 4

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,855

Underlying: Common Stock · 20,000 shares

Expires 2022-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted on November 7, 2012 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000017 · edgar.xml · nonDerivative · entry 3

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127430-17-000017 · edgar.xml · nonDerivative · entry 2

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.46 to $16.74, inclusive.

SEC source: 0001127430-17-000017 · edgar.xml · nonDerivative · entry 1

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127430-17-000013 · edgar.xml · derivative · entry 1

SULLIVAN EUGENE JEFFREY · CIK 0001637226 · Chief Med. & Scientific Ofc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,140

Underlying: Common Stock · 41,140 shares

Expires 2027-01-05

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000012 · edgar.xml · derivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,140

Underlying: Common Stock · 41,140 shares

Expires 2027-01-05

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000011 · edgar.xml · derivative · entry 1

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,820

Underlying: Common Stock · 65,820 shares

Expires 2027-01-05

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000010 · edgar.xml · derivative · entry 1

Lewis William · CIK 0001402051 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,530

Underlying: Common Stock · 175,530 shares

Expires 2027-01-05

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-17-000009 · edgar.xml · derivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,280

Underlying: Common Stock · 82,280 shares

Expires 2027-01-05

F1 · derivative.exercise_date: Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-16-000169 · edgar.xml · nonDerivative · entry 2

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F2 · price: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.74 to $13.00, inclusive.

SEC source: 0001127430-16-000167 · edgar.xml · nonDerivative · entry 2

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.75 to $12.81, inclusive.

SEC source: 0001127430-16-000169 · edgar.xml · nonDerivative · entry 1

Pellizzari Christine A · CIK 0001127430 · General Counsel & Corp. Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: The price in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.61 to $12.82, inclusive.

SEC source: 0001127430-16-000167 · edgar.xml · nonDerivative · entry 1

POTTER MYRTLE S · CIK 0001214130 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F1 · price: The price in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.88 to $12.91, inclusive.

SEC source: 0001127430-16-000162 · edgar.xml · derivative · entry 2

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,145

Underlying: Common Stock · 5,000 shares

Expires 2022-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-16-000162 · edgar.xml · nonDerivative · entry 1

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127430-16-000158 · edgar.xml · derivative · entry 6

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2023-03-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock Options granted under the Company's 2000 Stock Incentive Plan. On March 20, 2013, the Reporting Person was granted an option to purchase 50,000 shares of common stock. The option vests in two equal installments based upon the Company's satisfaction of two separate performance metrics. One such performance metric was met by the Company on February 26, 2015, resulting in vesting of the option as to 25,000 shares.

SEC source: 0001127430-16-000158 · edgar.xml · derivative · entry 5

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,855

Underlying: Common Stock · 20,000 shares

Expires 2022-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-16-000158 · edgar.xml · nonDerivative · entry 4

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $14.22 to $14.915.

SEC source: 0001127430-16-000158 · edgar.xml · nonDerivative · entry 3

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127430-16-000158 · edgar.xml · nonDerivative · entry 2

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $14.22 to $14.915.

SEC source: 0001127430-16-000158 · edgar.xml · nonDerivative · entry 1

Drechsler Andrew T · CIK 0001324734 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127430-16-000155 · edgar.xml · derivative · entry 9

Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,009 shares

Expires 2023-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

SEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 6

Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001127430-16-000155 · edgar.xml · nonDerivative · entry 5

Schaeffer Orlov S Nicole · CIK 0001401017 · SVP, HR & Corp. Svcs.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.